Neogen (NEOG) Stock Forecast, Price Target & Predictions
NEOG Stock Forecast
Neogen stock forecast is as follows: an average price target of $17.50 (represents a 15.13% upside from NEOG’s last price of $15.20) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
NEOG Price Target
The average price target for Neogen (NEOG) is $17.50 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $17.50 to $17.50. This represents a potential 15.13% upside from NEOG's last price of $15.20.
NEOG Analyst Ratings
According to 2 Wall Street analysts, Neogen's rating consensus is 'Buy'. The analyst rating breakdown for NEOG stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 1 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Neogen Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 06, 2024 | David Westenberg | Piper Sandler | $17.50 | $16.15 | 8.36% | 15.13% |
| Dec 14, 2022 | David Westenberg | Piper Sandler | $17.00 | $15.35 | 10.75% | 11.84% |
| Oct 09, 2022 | David Westenberg | Piper Sandler | $14.00 | $12.68 | 10.41% | -7.89% |
The latest Neogen stock forecast, released on Aug 06, 2024 by David Westenberg from Piper Sandler, set a price target of $17.50, which represents a 8.36% increase from the stock price at the time of the forecast ($16.15), and a 15.13% increase from NEOG last price ($15.20).
Neogen Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $17.50 |
| Last Closing Price | $15.20 | $15.20 | $15.20 |
| Upside/Downside | -100.00% | -100.00% | 15.13% |
In the current month, the average price target of Neogen stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Neogen's last price of $15.20. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 06, 2024 | Piper Sandler | Neutral | Neutral | Hold |
| Oct 10, 2023 | William Blair | Outperform | Outperform | Hold |
| Dec 14, 2022 | Piper Sandler | Neutral | Neutral | Hold |
| Nov 22, 2022 | William Blair | - | Outperform | Upgrade |
| Oct 09, 2022 | Piper Sandler | Neutral | Neutral | Hold |
Neogen's last stock rating was published by Piper Sandler on Aug 06, 2024. The company gave NEOG a "Neutral" rating, the same as its previous rate.
Neogen Financial Forecast
Neogen Revenue Forecast
| May 27 | Mar 27 | Dec 26 | Aug 26 | May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $228.99M | $241.81M | - | - | $132.35M | $140.09M | - | - | $128.31M | $127.42M | - | - | $109.33M | $109.07M | - |
| Avg Forecast | $281.90M | $263.25M | $247.85M | $239.45M | $267.85M | $250.25M | $236.55M | $229.50M | $256.01M | $237.48M | $226.19M | $215.05M | $225.83M | $229.61M | $232.85M | $231.10M | $227.72M | $218.87M | $228.30M | $135.75M | $138.37M | $130.00M | $129.06M | $121.20M | $122.32M | $106.73M | $115.16M | $105.79M | $112.15M | $102.42M |
| High Forecast | $282.27M | $263.59M | $248.17M | $239.76M | $268.20M | $250.57M | $236.86M | $229.80M | $256.34M | $237.92M | $226.54M | $215.05M | $225.83M | $229.81M | $236.20M | $231.40M | $228.02M | $219.15M | $228.60M | $137.14M | $139.78M | $131.33M | $130.38M | $122.44M | $123.57M | $107.82M | $116.34M | $106.87M | $113.30M | $103.46M |
| Low Forecast | $281.42M | $262.80M | $247.43M | $239.04M | $267.39M | $249.82M | $236.15M | $229.11M | $255.57M | $236.75M | $225.62M | $215.05M | $225.83M | $229.40M | $229.75M | $230.71M | $227.33M | $218.49M | $227.91M | $134.67M | $137.27M | $128.97M | $128.04M | $120.24M | $121.35M | $105.88M | $114.25M | $104.95M | $111.26M | $101.60M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 5 | 5 | 9 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 1.06% | - | - | 0.97% | 1.01% | - | - | 1.06% | 1.04% | - | - | 1.03% | 0.97% | - |
Neogen's average Quarter revenue forecast for Dec 23 based on 3 analysts is $232.85M, with a low forecast of $229.75M, and a high forecast of $236.20M. NEOG's average Quarter revenue forecast represents a 1.69% increase compared to the company's last Quarter revenue of $228.99M (Aug 23).
Neogen EBITDA Forecast
| May 27 | Mar 27 | Dec 26 | Aug 26 | May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 5 | 5 | 9 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $19.14M | $23.43M | - | - | $6.06M | $18.03M | - | - | $27.41M | $26.08M | - | - | $24.53M | $26.03M | - |
| Avg Forecast | $54.48M | $50.87M | $47.90M | $46.27M | $51.76M | $48.36M | $45.71M | $44.35M | $49.47M | $45.89M | $43.71M | $41.56M | $43.64M | $24.10M | $45.00M | $44.66M | $44.01M | $21.91M | $26.22M | $18.78M | $19.14M | $19.92M | $17.85M | $16.76M | $16.92M | $22.39M | $15.93M | $14.63M | $15.51M | $21.59M |
| High Forecast | $54.55M | $50.94M | $47.96M | $46.33M | $51.83M | $48.42M | $45.77M | $44.41M | $49.54M | $45.98M | $43.78M | $41.56M | $43.64M | $28.92M | $45.64M | $44.72M | $44.06M | $26.29M | $31.46M | $18.97M | $19.33M | $23.90M | $18.03M | $16.93M | $17.09M | $26.87M | $16.09M | $14.78M | $15.67M | $25.91M |
| Low Forecast | $54.38M | $50.78M | $47.81M | $46.19M | $51.67M | $48.28M | $45.63M | $44.27M | $49.39M | $45.75M | $43.60M | $41.56M | $43.64M | $19.28M | $44.40M | $44.58M | $43.93M | $17.53M | $20.97M | $18.63M | $18.99M | $15.93M | $17.71M | $16.63M | $16.78M | $17.91M | $15.80M | $14.52M | $15.39M | $17.27M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.43% | 0.53% | - | - | 0.32% | 0.94% | - | - | 1.64% | 1.54% | - | - | 1.68% | 1.68% | - |
3 analysts predict NEOG's average Quarter EBITDA for Dec 23 to be $45.00M, with a high of $45.64M and a low of $44.40M. This is 135.16% upper than Neogen's previous annual EBITDA (Aug 23) of $19.14M.
Neogen Net Income Forecast
| May 27 | Mar 27 | Dec 26 | Aug 26 | May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 5 | 5 | 9 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.50M | $5.57M | - | - | $5.21M | $14.96M | - | - | $17.08M | $15.76M | - | - | $15.86M | $16.35M | - |
| Avg Forecast | $17.34M | $15.17M | $8.67M | $-2.17M | $10.83M | $8.67M | $4.33M | $-6.50M | $10.11M | $5.06M | $-2.17M | $-7.22M | $-2.17M | $9.88M | $5.42M | $5.42M | $2.89M | $8.98M | $15.13M | $22.75M | $24.92M | $8.16M | $36.84M | $34.67M | $29.98M | $13.89M | $33.95M | $29.80M | $32.23M | $14.01M |
| High Forecast | $17.36M | $15.19M | $8.68M | $-2.16M | $10.85M | $8.68M | $4.34M | $-6.49M | $10.13M | $5.06M | $-1.97M | $-7.21M | $-2.16M | $11.85M | $5.43M | $5.43M | $2.89M | $10.78M | $18.16M | $23.06M | $25.25M | $9.80M | $37.33M | $35.13M | $30.37M | $16.67M | $34.40M | $30.19M | $32.66M | $16.81M |
| Low Forecast | $17.30M | $15.13M | $8.65M | $-2.17M | $10.81M | $8.65M | $4.32M | $-6.51M | $10.09M | $5.04M | $-2.36M | $-7.24M | $-2.17M | $7.90M | $5.06M | $5.41M | $2.88M | $7.18M | $12.11M | $22.52M | $24.66M | $6.53M | $36.46M | $34.31M | $29.67M | $11.11M | $33.60M | $29.49M | $31.90M | $11.21M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.28% | 1.93% | - | - | 0.23% | 0.60% | - | - | 0.49% | 0.53% | - | - | 0.53% | 0.51% | - |
Neogen's average Quarter net income forecast for Dec 23 is $5.42M, with a range of $5.06M to $5.43M. NEOG's average Quarter net income forecast represents a 260.44% increase compared to the company's last Quarter net income of $1.50M (Aug 23).
Neogen SG&A Forecast
| May 27 | Mar 27 | Dec 26 | Aug 26 | May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 5 | 5 | 9 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $90.90M | $92.70M | - | - | $51.33M | $43.14M | - | - | $33.94M | $33.36M | - | - | $27.53M | $28.33M | - |
| Avg Forecast | $95.09M | $88.80M | $83.61M | $80.77M | $90.35M | $84.41M | $79.79M | $77.42M | $86.36M | $80.11M | $76.30M | $72.54M | $76.18M | $84.35M | $78.55M | $77.96M | $76.82M | $76.68M | $61.21M | $45.20M | $46.07M | $69.71M | $42.98M | $40.36M | $40.73M | $35.14M | $38.35M | $35.23M | $37.35M | $32.68M |
| High Forecast | $95.21M | $88.91M | $83.71M | $80.88M | $90.47M | $84.52M | $79.90M | $77.52M | $86.47M | $80.26M | $76.42M | $72.54M | $76.18M | $101.22M | $79.67M | $78.06M | $76.92M | $92.02M | $73.45M | $45.67M | $46.55M | $83.65M | $43.41M | $40.77M | $41.15M | $42.17M | $38.74M | $35.59M | $37.73M | $39.22M |
| Low Forecast | $94.93M | $88.65M | $83.46M | $80.63M | $90.20M | $84.27M | $79.66M | $77.28M | $86.21M | $79.86M | $76.11M | $72.54M | $76.18M | $67.48M | $77.50M | $77.82M | $76.68M | $61.35M | $48.97M | $44.84M | $45.71M | $55.77M | $42.63M | $40.04M | $40.41M | $28.11M | $38.04M | $34.95M | $37.05M | $26.14M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.17% | 1.21% | - | - | 1.14% | 0.94% | - | - | 0.84% | 0.82% | - | - | 0.78% | 0.76% | - |
Neogen's average Quarter SG&A projection for Dec 23 is $78.55M, based on 3 Wall Street analysts, with a range of $77.50M to $79.67M. The forecast indicates a -13.60% fall compared to NEOG last annual SG&A of $90.90M (Aug 23).
Neogen EPS Forecast
| May 27 | Mar 27 | Dec 26 | Aug 26 | May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 5 | 5 | 9 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.03 | - | - | $0.05 | $0.14 | - | - | $0.16 | $0.15 | - | - | $0.15 | $0.15 | - |
| Avg Forecast | $0.08 | $0.07 | $0.04 | $-0.01 | $0.05 | $0.04 | $0.02 | $-0.03 | $0.05 | $0.02 | $-0.01 | $-0.03 | $-0.01 | $0.01 | $0.03 | $0.03 | $0.01 | $-0.01 | $-0.08 | $0.10 | $0.12 | $0.12 | $0.17 | $0.16 | $0.14 | $0.13 | $0.16 | $0.14 | $0.15 | $0.14 |
| High Forecast | $0.08 | $0.07 | $0.04 | $-0.01 | $0.05 | $0.04 | $0.02 | $-0.03 | $0.05 | $0.02 | $-0.01 | $-0.03 | $-0.01 | $0.02 | $0.03 | $0.03 | $0.01 | $-0.01 | $-0.08 | $0.11 | $0.12 | $0.12 | $0.17 | $0.16 | $0.14 | $0.13 | $0.16 | $0.14 | $0.15 | $0.14 |
| Low Forecast | $0.08 | $0.07 | $0.04 | $-0.01 | $0.05 | $0.04 | $0.02 | $-0.03 | $0.05 | $0.02 | $-0.01 | $-0.03 | $-0.01 | $0.01 | $0.02 | $0.02 | $0.01 | $-0.02 | $-0.08 | $0.10 | $0.11 | $0.12 | $0.17 | $0.16 | $0.14 | $0.13 | $0.16 | $0.14 | $0.15 | $0.13 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.94% | - | - | 0.48% | 1.22% | - | - | 0.99% | 1.06% | - | - | 1.09% | 1.03% | - |
According to 1 Wall Street analysts, Neogen's projected average Quarter EPS for Aug 23 is $0.03, with a low estimate of $0.02 and a high estimate of $0.03. This represents a -3.10% decrease compared to NEOG previous annual EPS of $0.03 (May 23).
Neogen Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics | $3.14 | $14.00 | 345.86% | Buy |
| GTH | Genetron | $4.03 | $10.00 | 148.14% | - |
| MYGN | Myriad Genetics | $15.22 | $29.00 | 90.54% | Hold |
| XGN | Exagen | $3.00 | $5.00 | 66.67% | Buy |
| ICLR | ICON Public Limited Company | $187.22 | $309.60 | 65.37% | Buy |
| IQV | IQVIA | $191.04 | $266.65 | 39.58% | Buy |
| MEDP | Medpace | $308.93 | $399.20 | 29.22% | Hold |
| QGEN | Qiagen | $40.99 | $51.89 | 26.59% | Buy |
| SHC | Sotera Health Company | $13.88 | $17.43 | 25.58% | Buy |
| NEOG | Neogen | $15.20 | $17.50 | 15.13% | Buy |
| RDNT | RadNet | $79.09 | $69.00 | -12.76% | Buy |
| OLK | Olink AB (publ) | $26.08 | $21.50 | -17.56% | Hold |